Compare BANF & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BANF | NOVT |
|---|---|---|
| Founded | 1984 | 1968 |
| Country | United States | United States |
| Employees | 2135 | N/A |
| Industry | Major Banks | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.9B |
| IPO Year | N/A | 1999 |
| Metric | BANF | NOVT |
|---|---|---|
| Price | $106.06 | $116.63 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $124.00 | ★ $133.00 |
| AVG Volume (30 Days) | 91.0K | ★ 391.1K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | $6.10 | $8.71 |
| Revenue Next Year | $3.92 | $6.47 |
| P/E Ratio | ★ $16.38 | $81.06 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $97.02 | $98.27 |
| 52 Week High | $138.15 | $149.95 |
| Indicator | BANF | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 32.18 |
| Support Level | N/A | $111.49 |
| Resistance Level | $115.92 | $126.36 |
| Average True Range (ATR) | 3.95 | 7.01 |
| MACD | -0.86 | -2.72 |
| Stochastic Oscillator | 11.27 | 0.94 |
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.